Calvin Sternick

Stock Analyst at JP Morgan

(1.90)
# 3,256
Out of 5,090 analysts
19
Total ratings
38.46%
Success rate
6.1%
Average return

Stocks Rated by Calvin Sternick

U.S. Physical Therapy
Mar 19, 2025
Maintains: Overweight
Price Target: $120$110
Current: $75.03
Upside: +46.61%
Centene
Jul 10, 2024
Maintains: Neutral
Price Target: $85$80
Current: $38.34
Upside: +108.66%
PACS Group
May 6, 2024
Initiates: Overweight
Price Target: $27
Current: $30.76
Upside: -12.22%
Universal Health Services
Mar 13, 2024
Maintains: Neutral
Price Target: $144$182
Current: $231.08
Upside: -21.24%
Tenet Healthcare
Nov 17, 2023
Maintains: Overweight
Price Target: $91$81
Current: $210.00
Upside: -61.43%
Molina Healthcare
Nov 17, 2023
Maintains: Overweight
Price Target: $367$392
Current: $151.86
Upside: +158.13%